Innovation Metals Corp. and Hexagon Resources Limited Form Joint Venture for the Commercialization of RapidSX™ Technology for Rare-Earth Separation
10 oct. 2019 10h12 HE
|
Innovation Metals Corp.
TORONTO, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC”) is pleased to announce the execution of a binding Investment Agreement (“BIA”) with Hexagon Resources Limited (ASX:HXG)...
U.S. Defense Reports Immuron’s Travelan® demonstrates broad reactivity to Vibrio cholera strains from Southeast Asia indicating broad potential for prevention of travelers’ diarrhea
04 sept. 2019 06h00 HE
|
Immuron Limited
Key Highlights: Major goal of study was to evaluate Travelan®’s ability to bind and react to a variety of infectious Vibrio cholera strains from Southeast Asia Pathogenic bacteria evaluated in study...
Immuron to Commence Non-Deal Investor Roadshow
16 août 2019 06h00 HE
|
Immuron Limited
MELBOURNE, Australia, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
Immuron Prices Underwritten Public Offering of ADSs
17 juil. 2019 06h00 HE
|
Immuron Limited
MELBOURNE, Australia, July 17, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
Immuron North American revenue surges by 52% in FY19
16 juil. 2019 06h00 HE
|
Immuron Limited
Key Highlights: Immuron FY19 revenue surged by 52% in North America, reaching $1.16M.In the USA, FY19 Travelan® sales exceeded the $1M AUD milestone for the first time and grew by +32% to $1.02M AUD....
Immuron Directors Increase Shareholdings in the Company
25 juin 2019 06h00 HE
|
Immuron Limited
MELBOURNE, Australia, June 25, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company wishes to advise that two of its Directors, Mr Peter...
Immuron to Commence US Non-Deal Institutional Investor Roadshow
19 juin 2019 08h00 HE
|
Immuron Limited
MELBOURNE, Australia, June 19, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
Immuron Announces the Closing of Public Offering of ADSs
30 mai 2019 08h00 HE
|
Immuron Limited
MELBOURNE, Australia, May 30, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin...
Immuron Prices Underwritten Public Offering of ADSs
23 mai 2019 21h10 HE
|
Immuron Limited
MELBOURNE, Australia,, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
Immuron Announces Proposed Public Offering of ADSs
23 mai 2019 16h45 HE
|
Immuron Limited
MELBOURNE, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin...